Clinical Equipoise

Clinical equipoise is the ethical principle that a randomized controlled trial is justified only when there is genuine uncertainty within the expert medical community about which treatment is superior. If doctors already know that Treatment A is better than Treatment B, it would be unethical to randomly assign patients to B. The concept, developed by Benjamin Freedman in 1987, distinguishes between individual equipoise (one doctor's uncertainty) and community equipoise (the medical community's collective uncertainty). In practice, equipoise is surprisingly common — many established treatments have never been rigorously compared to alternatives, and expert opinion often divides genuinely. The concept creates a productive tension: equipoise is necessary to justify a trial ethically, but every trial aims to destroy equipoise by producing evidence that favors one treatment.

When to use it

When deciding whether an experiment or comparison is ethically and practically justified, evaluating whether you're genuinely uncertain about which option is better, designing fair tests between alternatives, or recognizing when your 'uncertainty' is performative rather than genuine.

How it can help

This model teaches a profound lesson about intellectual honesty: you can only learn from genuine uncertainty. If you've already decided which option is better before testing, your 'test' is theater, not inquiry. In business, clinical equipoise translates to genuine openness to experimental results — running an A/B test when you've already decided which version to ship isn't equipoise, it's confirmation theater. The concept also helps you distinguish between situations where you genuinely don't know the answer (experiment is warranted) and situations where evidence already points clearly one way (just implement the better option). It calibrates when to experiment vs.